Morning Watch List: Build-A-Bear Workshop Inc. (NYSE:BBW), Marinus Pharmaceuticals (NASDAQ:MRNS), Baidu Inc (NASDAQ:BIDU), Allied World Assurance Company (NYSE:AWH), INSYS Therapeutics (NASDAQ:INSY)

On Tuesday shares of Build-A-Bear Workshop Inc. (NYSE:BBW) closed at $20.55. Company’s sales growth for last 5 years was -0.20% and EPS growth for next 5 years is recorded as 30.00%. Build-A-Bear Workshop, Inc. (NYSE:BBW), an interactive entertainment retailer of customized stuffed animals, announced the appointment of Chris Hurt to the position of chief operations officer effective April 15, 2015.

Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) in last trading activity increased 2.55% to close at $9.24. Company weekly performance is 3.94% while its quarterly performance stands at -34.00%. Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) is -44.34% away from its 52 week high.

On last trading day Baidu Inc (ADR) (NASDAQ:BIDU) moved down -0.69% to close at $213.91. Its volatility for the week is 2.55% while volatility for the month is 2.18%. BIDU’s sales growth for past 5 years was 61.60% and its EPS growth for past 5 years was 48.40%. Baidu Inc (ADR) (NASDAQ:BIDU) monthly performance is 4.63%. On April Baidu, Inc. (NASDAQ:BIDU), announced that it will report its financial results for the first quarter ended March 31, 2015, after the U.S. market closes on April 29, 2015.

Allied World Assurance Company Holdings, AG (NYSE:AWH) has 2.30% insider ownership while its institutional ownership stands at 88.60%. In last trading activity company’s stock closed at $42.36. Allied World Assurance Company Holdings, AG (NYSE:AWH) announced that Jonathan Evans will join the board of directors and become the Non?Executive Chairman of Allied World Managing Agency Limited, its Lloyd’s managing agency, subject to U.K. regulatory approval.

On last trading day INSYS Therapeutics, Inc. (NASDAQ:INSY) increased 1.21% to close at $60.22. Its volatility for the week is 4.19% while volatility for the month is 4.50%. INSY’s EPS growth for past 5 years was 17.30%. INSYS Therapeutics, Inc. (NASDAQ:INSY) monthly performance is -0.15%. Insys Therapeutics (NASDAQ:INSY)‘s stock had its “market perform” rating reissued by Oppenheimer in a research note issued on Tuesday.

Leave a Reply

Your email address will not be published. Required fields are marked *

*